To review if ESR2 may be considered a prognostic factor, we examined the influence of ESR2 mRNA expression level on overall survival (OS) and disease-free survival (DFS) across various cancer types within the TCGA database (Figure 3). The gene discussed is ESR2; the disease is cancer.